DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @AmericanBanking | 6 |
| @portefeuillefun | 4 |
| @WatchlistN | 3 |
| @OlympiaReport | 2 |
| @ConsumerFeed | 2 |
Recent Tweets for DRNA
 |
@BioBoyScout @RNAiAnalyst 2/5 $DRNA's GalXC™ exact strategy for addressing off-target effects (OTE) is unknown, except for "Exqu… https://t.co/pcvUxOsKlR May 22nd 2019, 8:05am |
 |
@AmericanBanking Dicerna Pharmaceuticals Inc Forecasted to Earn Q2 2019 Earnings of -$0.34 Per Share $DRNA https://t.co/OMgTonvFy2 #stocks May 22nd 2019, 7:05am |
 |
@TranscriptDaily Dicerna Pharmaceuticals Inc Forecasted to Earn Q2 2019 Earnings of -$0.34 Per Share $DRNA https://t.co/V6hEQ40S9m May 22nd 2019, 7:05am |
 |
@dailypoliticaln Dicerna Pharmaceuticals Inc $DRNA Expected to Announce Earnings of -$0.31 Per Share https://t.co/juiUhaBeit May 22nd 2019, 3:05am |
|
@dailypoliticaln Dicerna Pharmaceuticals Inc Expected to Earn Q2 2019 Earnings of -$0.35 Per Share $DRNA https://t.co/5BqACeXnax May 22nd 2019, 1:05am |
 |
@ConsumerFeed Q2 2019 Earnings Estimate for Dicerna Pharmaceuticals Inc $DRNA Issued By SunTrust Banks https://t.co/TpxabXj6FV May 21st 2019, 1:05am |
 |
@HCWCO In today’s Morning Summary, $DRNA announced the dosing of the first patient in its Phase 1 trial of treatment for… https://t.co/VWtWfn0g23 May 20th 2019, 10:05am |
|
@ConsumerFeed Dicerna Pharmaceuticals $DRNA PT Lowered to $20.00 https://t.co/5C3Baq3Zj0 May 20th 2019, 6:05am |
|
@AmericanBanking Analysts Set Expectations for Dicerna Pharmaceuticals Inc’s Q2 2019 Earnings $DRNA https://t.co/YnyT9knCxL #stocks May 20th 2019, 1:05am |
|
@AmericanBanking Dicerna Pharmaceuticals Inc $DRNA Expected to Post Earnings of -$0.31 Per Share https://t.co/nZzcfI8Ii8 #stocks May 19th 2019, 6:05pm |
 |
@1MinuteStock Wondering about risks of $DRNA? The 21-day volatility is 14.21% https://t.co/y8VUq53r04 May 19th 2019, 2:05pm |
 |
@WeekHerald Dicerna Pharmaceuticals $DRNA Downgraded by Zacks Investment Research to Sell https://t.co/7raO0L5Sgr May 19th 2019, 9:05am |
 |
@OlympiaReport Dicerna Pharmaceuticals $DRNA Downgraded by Zacks Investment Research to Sell https://t.co/3nVYSkbsL2 May 19th 2019, 9:05am |
 |
@ThisLincolnian Dicerna Pharmaceuticals $DRNA Downgraded by Zacks Investment Research to Sell https://t.co/pIb797jEc7 May 19th 2019, 9:05am |
 |
@SwingTradeBot Recent $DRNA technical alerts: Non-ADX 1,2,3,4 Bearish plus 10 more alerts... https://t.co/SvLQTafHg8 May 19th 2019, 9:05am |
 |
@WKRBNews Dicerna Pharmaceuticals $DRNA Stock Rating Lowered by Zacks Investment Research https://t.co/YGW276pYwf #markets May 18th 2019, 11:05am |
 |
@macondailynews SunTrust Banks Lowers Dicerna Pharmaceuticals $DRNA Price Target to $20.00 https://t.co/9F35LhJObT May 18th 2019, 8:05am |
 |
@mikegoodma $DRNA’ s 3 deals call for it to discover & develop preclinical candidates. The deal w Boehringer against hepatic ta… https://t.co/3tiNdai7JL May 17th 2019, 2:05pm |
 |
@TheMarketsDaily Dicerna Pharmaceuticals $DRNA PT Lowered to $20.00 https://t.co/iqjh1clPdf May 17th 2019, 1:05pm |
 |
@WatchlistN Dicerna Pharmaceuticals $DRNA Downgraded by Zacks Investment Research https://t.co/Bzb0Er2RO7 May 17th 2019, 8:05am |
|
@AmericanBanking Dicerna Pharmaceuticals $DRNA PT Lowered to $20.00 at SunTrust Banks https://t.co/4gcQQM9jdV #stocks May 16th 2019, 5:05pm |
|
@WatchlistN SunTrust Banks Lowers Dicerna Pharmaceuticals $DRNA Price Target to $20.00 https://t.co/JBDsaIXgr8 May 16th 2019, 5:05pm |
|
@TranscriptDaily Dicerna Pharmaceuticals $DRNA Cut to Sell at Zacks Investment Research https://t.co/7NfPKGN4au May 16th 2019, 1:05pm |
 |
@ToothFrank $DRNA $DRNA Dicerna Pharmaceuticalssaid pre-market Thursday that it has dosed the first patient in its Phase 1 clin… https://t.co/wUM575YKUL May 16th 2019, 9:05am |
 |
@RNAiAnalyst @BuffSoldierTwo depends on price; still some time to Q4 read-out. $DRNA May 16th 2019, 8:05am |
 |
@BuffSoldierTwo @RNAiAnalyst $DRNA Dirk, how soon till this gets partnered. Will you be buying ahead of that? May 16th 2019, 8:05am |
 |
@NewsToDesk $DRNA: Dicerna begins patient dosing in early-stage HBV study: https://t.co/7OY3q4dMju May 16th 2019, 8:05am |
 |
@MarketCurrents $DRNA - Dicerna begins patient dosing in early-stage HBV study https://t.co/CvlMiQFMM9 May 16th 2019, 7:05am |
|
@NewsToDesk $DRNA: Dicerna Announces Dosing of First Patient in Phase 1 Clinical Trial …: https://t.co/YsasdjTLC1 May 16th 2019, 7:05am |
|
@TheMarketsDaily Dicerna Pharmaceuticals $DRNA Downgraded by Zacks Investment Research to “Sell” https://t.co/4aYNQ0xkoK May 15th 2019, 9:05pm |
 |
@portefeuillefun Sold 1k $DRNA at $11.46, now 1.5k #vssporte shares. May 14th 2019, 10:05am |
|
@OlympiaReport Comparing Dicerna Pharmaceuticals $DRNA and Cotinga Pharmaceuticals $COTQF https://t.co/aOQSl7lstJ May 14th 2019, 2:05am |
 |
@DataTrials $DRNA Phase 1 Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria… Estimated… https://t.co/pc5CK2qvjU May 13th 2019, 4:05pm |
|
@mikegoodma In 1Q call, Fambrough clarifies $DRNA approach to HBV. In a multi-pronged approach, RNAi is uniquely suited to redu… https://t.co/5SVqn0y9uR May 13th 2019, 2:05pm |
|
@portefeuillefun Bought 1.5k $DRNA at $11.00, now 2.5k #vssporte shares. May 13th 2019, 9:05am |
|
@portefeuillefun Buy 1.5k $DRNA, limit $11.50, GTC. #vssporte May 13th 2019, 6:05am |
 |
@intercooleronli Dicerna Pharmaceuticals $DRNA Shares Down 6.2% on Disappointing Earnings https://t.co/XI74AUmHMe #investingnews May 12th 2019, 1:05am |
 |
@ledgerzette Dicerna Pharmaceuticals $DRNA Shares Down 6.2% on Disappointing Earnings https://t.co/tTNMfvDAIS #stocks May 12th 2019, 1:05am |
 |
@bulletin_en Comparing of Coherus BioSciences Inc. $DRNA https://t.co/W5q0ukFpdk May 11th 2019, 6:05pm |
|
@RNAiAnalyst $DRNA, in their frenzy to catch up w/ $ALNY on PH, playing a wild PK/PD guessing game. After single dose phase I/II… https://t.co/kExgC6U8Bm May 11th 2019, 4:05pm |
|
@dakotafinancial Dicerna Pharmaceuticals $DRNA Issues Earnings Results https://t.co/tIKNeECvfI May 11th 2019, 11:05am |
|
@WatchlistN Dicerna Pharmaceuticals $DRNA Announces Quarterly Earnings Results, Misses Expectations By $0.16 EPS https://t.co/aULgYNbAYE May 11th 2019, 11:05am |
|
@AmericanBanking Financial Survey: Cotinga Pharmaceuticals $COTQF versus Dicerna Pharmaceuticals $DRNA https://t.co/LtTlTEmFVX #stocks May 11th 2019, 7:05am |
 |
@bbnsnews Dicerna Pharmaceuticals $DRNA Issues Earnings Results https://t.co/AdjELY0hqL May 11th 2019, 12:05am |
|
@AmericanBanking Dicerna Pharmaceuticals $DRNA Releases Earnings Results, Misses Estimates By $0.16 EPS https://t.co/JCnhcA3dSu #stocks May 11th 2019, 12:05am |
|
@derekavinay RT @mikegoodma: 2H data I'm looking forward to: $DRNA P1 in HBV; $MGEN P2 in keloids & MRG-110 (partnered w Servier) with P1s in heart fail… May 10th 2019, 7:05pm |
 |
@StockTexts $DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 10-Q https://t.co/emgkTfa8BV May 10th 2019, 3:05pm |
|
@portefeuillefun RT @mikegoodma: $DRNA 1Q19 call. PHYOX2, a pivotal trial in 36 pts w PH1 & PH2, will begin dosing w a fixed monthly dose in 2Q19. Fambrough… May 10th 2019, 10:05am |
 |
@ProVesting $DRNA: Dicerna Pharmaceuticals, Inc. (DRNA) CEO Douglas Fambrough on …: https://t.co/sHBHqbMKxT May 9th 2019, 11:05pm |
 |
@SiteFocusHQ $DRNA Qualitative Analysis of recent earnings identified Dicerna Pharmaceuticals, Inc (NASDAQ: DRNA ) business focu… https://t.co/BbPqyZR9C8 May 9th 2019, 11:05pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.